Original paper
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
Abstract
The successive emergences and accelerating spread of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineages and evolved resistance to some ongoing clinical therapeutics increase the risks associated with the coronavirus disease 2019 (COVID-19) pandemic. An urgent intervention for broadly effective therapies to limit the morbidity and mortality of COVID-19 and future transmission events from SARS-related coronaviruses...
Paper Details
Title
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
Published Date
Aug 17, 2021
Journal
Volume
12
Issue
1